Robert Walker | Executive Vice President, Head of R&D
Novavax

Dr. Walker is Executive Vice President and Head of Research & Development and previously served as Novavax’s Chief Medical Officer. A specialist in internal medicine and pulmonary and critical care medicine, Dr. Walker has more than 30 years of experience in drug and vaccine development within the private and public sectors. He joined Novavax in 2022, after leading the development of RSV and COVID-19 vaccines at Meissa Vaccines, Inc. He previously served as Chief Medical Officer at the Biomedical Advanced Research & Development Authority (BARDA) in the U.S. Department of Health and Human Services and provided clinical development expertise to medical countermeasure programs, including Operation Warp Speed for COVID-19 vaccines and therapeutics, and to federal emergency responses to Zika, Ebola and influenza epidemics. Dr. Walker earned his Doctor of Medicine degree from the University of Maryland. He completed his internal medicine training at The George Washington University and completed his fellowship in pulmonary and critical care medicine at the University of Pennsylvania.